6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
Filana Therapeutics Increases Share Authorization and Extends Incentive Plan
Reports Q1 2026 Financial Results and Business Update
Annual Report to Security Holders
Changes in Board, Management or Compensation
Reports Fourth Quarter and Full Year 2025 Financial Results
Announces Name Change to Filana Therapeutics, Inc.
Announces Closure of U.S. Department of Justice Investigation
Entry into a Material Definitive Agreement
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus Filed Pursuant to Rule 424(b)(2)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Certificate
Registration of Securities
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Registration of Securities under Section 12(g)
Submission Upload
Correspondence